GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Amplia Therapeutics Ltd (OTCPK:INNMF) » Definitions » Accounts Payable

Amplia Therapeutics (Amplia Therapeutics) Accounts Payable : $0.33 Mil (As of Sep. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Amplia Therapeutics Accounts Payable?

Amplia Therapeutics's Accounts Payable for the quarter that ended in Sep. 2023 was $0.33 Mil.

Amplia Therapeutics's quarterly Accounts Payable declined from Sep. 2022 ($0.28 Mil) to Mar. 2023 ($0.23 Mil) but then increased from Mar. 2023 ($0.23 Mil) to Sep. 2023 ($0.33 Mil).

Amplia Therapeutics's annual Accounts Payable declined from Mar. 2021 ($0.32 Mil) to Mar. 2022 ($0.27 Mil) and declined from Mar. 2022 ($0.27 Mil) to Mar. 2023 ($0.23 Mil).


Amplia Therapeutics Accounts Payable Historical Data

The historical data trend for Amplia Therapeutics's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amplia Therapeutics Accounts Payable Chart

Amplia Therapeutics Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.28 0.30 0.32 0.27 0.23

Amplia Therapeutics Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.25 0.27 0.28 0.23 0.33

Amplia Therapeutics Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.


Amplia Therapeutics Accounts Payable Related Terms

Thank you for viewing the detailed overview of Amplia Therapeutics's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Amplia Therapeutics (Amplia Therapeutics) Business Description

Traded in Other Exchanges
Address
350 Queen Street, Level 17, Melbourne, VIC, AUS, 3000
Amplia Therapeutics Ltd is an Australian pharmaceutical company advancing a pipeline of Focal Adhesion Kinase (FAK) inhibitors for cancer and fibrosis. Its molecule, AMP945 is a pure-play inhibitor, while the second molecule, AMP886, is a multi-action molecule that hits two other important cancer pathways - VEGFR3 and FLT3.

Amplia Therapeutics (Amplia Therapeutics) Headlines